Drug developed for lung disease may slow biological aging in surprising ‘bonus’

The story
Rentosertib, an AI-discovered drug for idiopathic pulmonary fibrosis, made patients appear three to four years biologically younger in a clinical trial.
How other outlets covered this
Compare allAlto found this story at 3 outlets. Same event, different framing — compare the headlines.
How this story developed
Full timelineAlto has tracked this across 3 days of coverage from 3 outlets.
- Drug developed for lung disease may slow biological aging in surprising ‘bonus’You are here
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events